The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture
Abstract
Saturated very long chain fatty acids (VLCFAs; > or =C22:0) accumulate in X-linked adrenoleukodystrophy (X-ALD, OMIM 300100), a severe hereditary neurodegenerative disease, due to peroxisomal impairment. Previous studies analysed the development of X-ALD in humans and gene knockout animal models. However, the toxic effect of VLCFA leading to severe symptoms with progressive and multifocal demyelination, adrenal insufficiency and inflammation still remains unclear. To understand the toxic effects of VLCFA in the brain, here we exposed neural cells to VLCFA and analysed the cellular consequences. We found that oligodendrocytes and astrocytes challenged with docosanoic- (C22:0), tetracosanoic- (C24:0) and hexacosanoic acids (C24:0) die within 24 h. VLCFA-induced depolarization of mitochondria in situ and increased intracellular Ca2+ level in all three brain cell types provides indications about the mechanism of toxicity of VLCFA. Interestingly, VLCFAs affect to the largest degree the myelin-producing oligodendrocytes. In isolated mitochondria, VLCFAs exert a detrimental effect by affecting the inner mitochondrial membrane and promoting the permeability transition. In conclusion, we suggest that there is a potent toxic activity of VLCFA due to dramatic cell physiological effects with mitochondrial dysfunction and Ca2+ deregulation. This provides the first evidence for mitochondrial-based cell death mechanisms in neurodegenerative disease with peroxisomal defects and subsequent VLCFA accumulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A direct cytotoxic effect on oligodendrocyte and astrocytes has been observed in rats, following exposure to C26:0 lipids (14).”
From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [14]
Citations
Cites
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.
McCarthy, K. D., & de Vellis, J. (1980) · The Journal of Cell Biology · doi:10.1083/jcb.85.3.890 · Cited by 3,845
Korshunov, S. S., Skulachev, V. P., & Starkov, A. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01159-9 · Cited by 1,727
Generation of reactive oxygen species by the mitochondrial electron transport chain
Liu, Y., Fiskum, G., & Schubert, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00744.x · Cited by 1,260
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Peroxisomal and Mitochondrial Defects in the Cerebro-Hepato-Renal Syndrome
Goldfischer, S. L., Moore, C. L., Johnson, T., Spiro, A. J., Valsamis, M. P., Wisniewski, H. K., Ritch, R. H., Norton, W. T., Rapin, I., & Gartner, L. M. (1973) · Science · doi:10.1126/science.182.4107.62 · Cited by 791
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Selmaj, K. W., Raine, C. S., Cannella, B., & Brosnan, C. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115102 · Cited by 726
Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury
Arundine, M., & Tymianski, M. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3319-x · Cited by 647
Relationship between configuration, function, and permeability in calcium-treated mitochondria.
Hunter, D. R., Haworth, R. A., & Southard, J. H. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33220-9 · Cited by 619
Hajnóczky, G., Csordás, G., Das, S., Garcı́a-Pérez, C., Saotome, M., Roy, S. S., & Yi, M. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.08.016 · Cited by 613
ΔΨ m ‐Dependent and ‐independent production of reactive oxygen species by rat brain mitochondria
Votyakova, T. V., & Reynolds, I. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00548.x · Cited by 601
Cited by
Sorted by citations
Engelen, M., Kemp, S., de Visser, M., van Geel, B. M., Wanders, R. J., Aubourg, P., & Poll-The, B. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-51 · Cited by 562
Schönfeld, P., & Reiser, G. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.128 · Cited by 457
Self-citationMyelin Proteomics: Molecular Anatomy of an Insulating Sheath
Jahn, O., Tenzer, S., & Werner, H. B. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8071-2 · Cited by 355
X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283
The peroxisome: an update on mysteries 2.0
Islinger, M., Völkl, A., Fahimi, H. D., & Schrader, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1722-5 · Cited by 296
The peroxisome: an update on mysteries
Islinger, M., Grille, S., Fahimi, H. D., & Schrader, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0941-4 · Cited by 283
Adrenoleukodystrophy—Neuroendocrine pathogenesis and redefinition of natural history
Kemp, S., Huffnagel, I. C., Linthorst, G. E., Wanders, R. J., & Engelen, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.90 · Cited by 275
Emerging roles for lipids in non-apoptotic cell death
Magtanong, L., Ko, P., & Dixon, S. J. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.25 · Cited by 267
Pathophysiology of X-linked adrenoleukodystrophy
Berger, J., Forss-Petter, S., & Eichler, F. S. (2014) · Biochimie · doi:10.1016/j.biochi.2013.11.023 · Cited by 238
Rönicke, R., Mikhaylova, M., Rönicke, S., Meinhardt, J., Schröder, U. H., Fändrich, M., Reiser, G., Kreutz, M. R., & Reymann, K. G. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.011 · Cited by 262
Self-citationEdvardson, S., Hama, H., Shaag, A., Gomori, J. M., Berger, I., Soffer, D., Korman, S. H., Taustein, I., Saada, A., & Elpeleg, O. N. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.10.010 · Cited by 218
Peroxisome‐mitochondria interplay and disease
Schrader, M., Costello, J. L., Godinho, L. F., & Islinger, M. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9819-7 · Cited by 232
Turk, B. R., Theda, C., Fatemi, A. S., & Moser, A. B. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10003 · Cited by 212
Rose, J., Brian, C., Pappa, A., Panayiotidis, M. I., & Franco, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.536682 · Cited by 196
Peroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
“Furthermore, it has been reported that VLCFA can disturb calcium homeostasis and causemitochondrial dysfunction in neuronal cell cultures aswell as toxicity to oligodendrocytes [133].”
BackgroundX-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
Engelen, M., Kemp, S., & Poll-The, B.-T. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0486-0 · Cited by 187
Peroxisomal ABC transporters: Structure, function and role in disease
Morita, M., & Imanaka, T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.009 · Cited by 183
Peroxisomes, lipid metabolism and lipotoxicity
Wanders, R. J. A., Ferdinandusse, S., Brites, P., & Kemp, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.001 · Cited by 169
Fatty acid metabolism in the progression and resolution of CNS disorders
Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167
Marquez, B., & Françoise Van Bambeke, A. (2011) · Current Drug Targets · doi:10.2174/138945011795378504 · Cited by 169
Pathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis
Singh, I., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00392.x · Cited by 148
Baarine, M., Andreoletti, P., Athias, A., Nury, T., Zarrouk, A., Ragot, K., Véjux, A., Riedinger, J., Kattan, Z., Bessède, G., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.058 · Cited by 123
Fatty Acids - Induced Lipotoxicity and Inflammation
Savary, S., Trompier, D., Andreoletti, P., Le Borgne, F., Demarquoy, J., & Lizard, G. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762729 · Cited by 111
Galea, E., Launay, N., Portero-Otin, M., Ruiz, M., Pamplona, R., Aubourg, P., Ferrer, I., & Pujol, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.005 · Cited by 108
Trompier, D., Véjux, A., Zarrouk, A., Gondcaille, C., Geillon, F., Nury, T., Savary, S., & Lizard, G. (2013) · Biochimie · doi:10.1016/j.biochi.2013.09.009 · Cited by 106
Schönfeld, P., & Reiser, G. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.018 · Cited by 99
Self-citationCurrent and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy
Berger, J., Pujol, A., Aubourg, P. R., & Forss‐Petter, S. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00393.x · Cited by 93
Zarrouk, A., Véjux, A., Nury, T., Hajj, H. I. E., Haddad, M., Cherkaoui‐Malki, M., Riedinger, J., Hammami, M., & Lizard, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/623257 · Cited by 94
Fourcade, S., Ferrer, I., & Pujol, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.041 · Cited by 80
Organelle interplay in peroxisomal disorders
Thoms, S., Grønborg, S. W., & Gärtner, J. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.05.002 · Cited by 74
Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
Schlüter, A., Espinosa, L., Fourcade, S., Galino, J., López, E., Ilieva, E., Morató, L., Asheuer, M., Cook, T., McLaren, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr536 · Cited by 72
How the brain fights fatty acids’ toxicity
Schönfeld, P., & Reiser, G. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105050 · Cited by 71
Self-citationHartley, M. D., Kirkemo, L. L., Banerji, T., & Scanlan, T. S. (2017) · Endocrinology · doi:10.1210/en.2016-1842 · Cited by 71
Schönfeld, P., & Reiser, G. (2016) · Aging and Disease · doi:10.14336/ad.2015.0823 · Cited by 71
Self-citationThyroid Hormone Signaling in Oligodendrocytes: from Extracellular Transport to Intracellular Signal
Lee, J. Y., & Petratos, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0013-1 · Cited by 71
Kumar, V., & Chandra, R. (2020) · 3 Biotech · doi:10.1007/s13205-020-02310-5 · Cited by 68
Launay, N., Ruíz, M., Grau, L., Ortega, F. J., Ilieva, E. V., Martínez, J. J., Galea, E., Ferrer, I., Knecht, E., Pujol, A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1655-9 · Cited by 63
Rönicke, S., Kruska, N., Kahlert, S., & Reiser, G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.005 · Cited by 63
Self-citationKruska, N., Schönfeld, P., Pujol, A., & Reiser, G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.005 · Cited by 56
Self-citationLipids in the Physiopathology of Hereditary Spastic Paraplegias
Darios, F. D., Mochel, F., & Stévanin, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00074 · Cited by 55
Fourcade, S., López-Erauskin, J., Ruiz, M., Ferrer, I., & Pujol, A. (2014) · Biochimie · doi:10.1016/j.biochi.2013.09.012 · Cited by 55
Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
Ranea‐Robles, P., Launay, N., Ruíz, M., Calingasan, N. Y., Dumont, M., Naudí, A., Portero‐Otín, M., Pamplona, R., Ferrer, I., Beal, M. F., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708604 · Cited by 55
Microglial dysfunction as a key pathological change in adrenomyeloneuropathy
Gong, Y., Sasidharan, N., Laheji, F., Frosch, M., Musolino, P., Tanzi, R., Kim, D. Y., Biffi, A., El Khoury, J., & Eichler, F. (2017) · Annals of Neurology · doi:10.1002/ana.25085 · Cited by 54
Leukodystrophies with late disease onset: an update
Köhler, W. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328338313a · Cited by 54
Nury, T., Sghaier, R., Zarrouk, A., Ménétrier, F., Uzun, T., Leoni, V., Caccia, C., Meddeb, W., Namsi, A., Sassi, K., et al. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.009 · Cited by 54
Baarine, M., Ragot, K., Genin, E. C., Hajj, H. I. E., Trompier, D., Andreoletti, P., Ghandour, M. S., Ménétrier, F., Cherkaoui‐Malki, M., Savary, S., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06311.x · Cited by 57
Khan, M., Singh, J., Gilg, A. G., Uto, T., & Singh, I. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002329 · Cited by 49
Therapy of X-linked adrenoleukodystrophy
Semmler, A., Köhler, W., Jung, H. H., Weller, M., & Linnebank, M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.9.1367 · Cited by 49
Baarine, M., Beeson, C., Singh, A. K., & Singh, I. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12992 · Cited by 48
C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man
van de Beek, M.-C., Dijkstra, I. M. E., van Lenthe, H., Ofman, R., Goldhaber-Pasillas, D., Schauer, N., Schackmann, M., Engelen-Lee, J.-Y., Vaz, F. M., Kulik, W., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154597 · Cited by 48
Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy
van de Beek, M.-C., Ofman, R., Dijkstra, I. M. E., Wijburg, F. A., Engelen, M., Wanders, R. J. A., & Kemp, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.003 · Cited by 48
Peroxisomal Disorders: A Review on Cerebellar Pathologies
Munter, S. D., Verheijden, S., Régal, L., & Baes, M. I. (2015) · Brain Pathology · doi:10.1111/bpa.12290 · Cited by 46
Baarine, M., Ragot, K., Athias, A., Nury, T., Kattan, Z., Genin, E. C., Andreoletti, P., Ménétrier, F., Riedinger, J.-M., Bardou, M., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2011.10.007 · Cited by 43
Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy
Raas, Q., van de Beek, M.-C., Forss‐Petter, S., Dijkstra, I. M. E., Deschiffart, A., Freshner, B. C., Stevenson, T. J., Jaspers, Y. R. J., Nagtzaam, L., Wanders, R. J. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142500 · Cited by 42
Rodríguez-Pascau, L., Vilalta, A., Cerrada, M., Traver, E., Forss-Petter, S., Weinhofer, I., Bauer, J., Kemp, S., Pina, G., Pascual, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc0555 · Cited by 40
Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy
Baarine, M., Khan, M., Singh, A., & Singh, I. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143238 · Cited by 38
Lee, D., Long, N. P., Jung, J., Kim, T., Na, E., Kang, Y. P., Kwon, S. W., & Jang, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.123 · Cited by 37
Singh, J., Khan, M., & Singh, I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017491 · Cited by 38
Mitochondrial Dysfunction in Demyelinating Diseases
Carvalho, K. S. (2013) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2013.09.001 · Cited by 35
Kim, Y., Nam, I., Lee, D., Bhandari, S., Charton, L., Kwak, S., Lim, J., Hong, K., Kim, S., Lee, J. N., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28954 · Cited by 37
Protective function of autophagy during VLCFA-induced cytotoxicity in a neurodegenerative cell model
Doria, M., Nury, T., Delmas, D., Moreau, T., Lizard, G., & Véjux, A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.016 · Cited by 33
Kimmerling, K. A., Oswald, S. J., Huebner, J. L., Little, D., Kraus, V. B., Kang, J. X., Wu, C., & Guilak, F. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02170-7 · Cited by 33
Groh, J., & Martini, R. (2017) · Glia · doi:10.1002/glia.23162 · Cited by 32
Zhou, J., Terluk, M. R., Orchard, P. J., Cloyd, J. C., & Kartha, R. V. (2021) · Biomedicines · doi:10.3390/biomedicines9121826 · Cited by 30
Ghzaiel, I., Zarrouk, A., Essadek, S., Martine, L., Hammouda, S., Yammine, A., Ksila, M., Nury, T., Meddeb, W., Tahri-Joutey, M., et al. (2022) · Steroids · doi:10.1016/j.steroids.2022.109032 · Cited by 32
Singh, I., Singh, A., & Contreras, M. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338327 · Cited by 28
Emerging cellular themes in leukodystrophies
Nowacki, J. C., Fields, A. M., & Fu, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.902261 · Cited by 29
Sivachenko, A., Gordon, H. B., Kimball, S. S., Gavin, E., Bonkowsky, J. L., & Letsou, A. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.022244 · Cited by 29
X-linked adrenoleukodystrophy and primary adrenal insufficiency
Cappa, M., Todisco, T., & Bizzarri, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1309053 · Cited by 28
Dietary rescue of lipotoxicity-induced mitochondrial damage in Peroxin19 mutants
Sellin, J., Wingen, C., Gosejacob, D., Senyilmaz, D., Hänschke, L., Büttner, S., Meyer, K., Bano, D., Nicotera, P., Teleman, A. A., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004893 · Cited by 27
Pillai, B. K., Jasuja, R., Simard, J. R., & Hamilton, J. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.043737 · Cited by 27
Bezine, M., Debbabi, M., Nury, T., Khalifa, R. B., Samadi, M. H., Cherkaoui‐Malki, M., Véjux, A., Raas, Q., Seze, J. D., Moreau, T., et al. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.03.006 · Cited by 27
Stradomska, T. J., Syczewska, M., Jamroz, E., Pleskaczyńska, A., Kruczek, P., Ciara, E., & Tylki‐Szymańska, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238796 · Cited by 25
Singh, J., Khan, M., Pujol, A., Baarine, M., & Singh, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070712 · Cited by 23
Singh, J., Khan, M., & Singh, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.01.004 · Cited by 21
Wang, R., Monuki, E. S., Powers, J., Schwartz, P. H., Watkins, P. A., Shi, Y., Moser, A. B., Shrier, D. A., Waterham, H. R., Nugent, D. J., et al. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9698-3 · Cited by 22
(2006) · Springer eBooks · doi:10.1007/3-540-29623-9_9160 · Cited by 21
Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1
Boyd, M. J., Collier, P. N., Clark, M. P., Deng, H., Kesavan, S., Ronkin, S. M., Waal, N. D., Wang, J., Cao, J., Li, P., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00948 · Cited by 19
The Role of Oxidative Stress and Inflammation in X-Link Adrenoleukodystrophy
Yu, J., Chen, T., Guo, X., Zafar, M. I., Li, H., Wang, Z., & Zheng, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.864358 · Cited by 22
The pathology of X-linked adrenoleukodystrophy: Tissue specific changes as a clue to pathophysiology
Yska, H. A. F., Engelen, M., & Bugiani, M. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03105-0 · Cited by 20
Hama, K., Nagai, T., 西澤, 千., Ikeda, K., Morita, M., Satoh, N., Nakanishi, H., Imanaka, T., Shimozawa, N., Taguchi, R., et al. (2013) · Lipids · doi:10.1007/s11745-013-3848-5 · Cited by 21
In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders
Sherry, E. B., Lee, P., & Choi, I.-Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1772-1 · Cited by 22
Nury, T., Doria, M., Lizard, G., & Véjux, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020641 · Cited by 20
Bezine, M., Maatoug, S., Khalifa, R. B., Debbabi, M., Zarrouk, A., Wang, Y., Griffiths, W. J., Nury, T., Samadi, M. H., Véjux, A., et al. (2018) · Biochimie · doi:10.1016/j.biochi.2018.02.008 · Cited by 19
Etiology and treatment of adrenoleukodystrophy: new insights from Drosophila
Gordon, H. B., Valdez, L., & Letsou, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031286 · Cited by 22
Beneficial reward-to-risk action of glucosamine during pathogenesis of osteoarthritis
Kang, Y.-H., Park, S., Ahn, C., Song, J., Kim, D., & Jin, E. (2015) · European journal of medical research · doi:10.1186/s40001-015-0176-7 · Cited by 19
Pujol, A. (2015) · Endocrine development · doi:10.1159/000439340 · Cited by 17
Verheijden, S., Beckers, L., Munter, S. D., Veldhoven, P. P. V., & Baes, M. I. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.009 · Cited by 18
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1
Come, J. H., Senter, T. J., Clark, M. P., Court, J. J., Gale-Day, Z. J., Gu, W., Krueger, E. B., Liang, J., Morris, M., Nanthakumar, S. S., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00944 · Cited by 16
ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
Volmrich, A. M., Cuénant, L. M., Forghani, I., Hsieh, S. L., & Shapiro, L. T. (2022) · The Application of Clinical Genetics · doi:10.2147/tacg.s359479 · Cited by 19
Nury, T., Yammine, A., Ménétrier, F., Zarrouk, A., Véjux, A., & Lizard, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-60204-8_3 · Cited by 17
Monternier, P., Singh, J., Parasar, P., Theurey, P., DeWitt, S. H., Jacques, V., Klett, E. L., Kaur, N., Nagaraja, T. N., Moller, D. E., et al. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12510 · Cited by 17
Marchetti, D. P., Reinhardt, L. S., Jacques, C. E. D., Guerreiro, G., Mescka, C. P., Deon, M., Coelho, D. D. M., Moura, D. J., Viario, A. G., Poletto, F. S., et al. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0626-1 · Cited by 17
Trompier, D., & Savary, S. (2013) · Colloquium Series on The Genetic Basis of Human Disease · doi:10.4199/c00075ed1v01y201303gbd004 · Cited by 17
Turk, B. R., Theda, C., Fatemi, A. S., & Moser, A. B. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.11.002 · Cited by 17
Peroxisomes attenuate cytotoxicity of very long-chain fatty acids
Ali, H., Kobayashi, M., Morito, K., Hasi, R. Y., Aihara, M., Hayashi, J., Kawakami, R., Tsuchiya, K., Sango, K., & Tanaka, T. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159259 · Cited by 17
Schönfeld, P., Kruska, N., & Reiser, G. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.09.008 · Cited by 15
Self-citationAntioxidant Response in Human X-Linked Adrenoleukodystrophy Fibroblasts
Petrillo, S., D’Amico, J., Nicita, F., Torda, C., Vasco, G., Bertini, E., Cappa, M., & Piemonte, F. (2022) · Antioxidants · doi:10.3390/antiox11112125 · Cited by 13
Pathophysiology of X-Linked Adrenoleukodystrophy: Updates on Molecular Mechanisms
Parasar, P., Kaur, N., & Singh, J. (2024) · Journal of Biotechnology and Biomedicine · doi:10.26502/jbb.2642-91280151 · Cited by 12
Adrenoleukodystrophy: a forgotten diagnosis in children with primary Addison's disease: Figure 1
Nascimento, M., Rodrigues, N., Espada, F., & Fonseca, M. (2012) · BMJ Case Reports · doi:10.1136/bcr-2012-006308 · Cited by 12
Metadata
- Authors
- Hein, S., Schonfeld, P., Kahlert, S., & Reiser, G.
- Affiliations
- Otto-von-Guericke-Universität Magdeburg (DE)
- Corresponding author
- Reiser, G.
- ORCID
- Kahlert, S.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-04
- Volume
- 17
- Issue
- 12
- Pages
- 1750-1761
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2167261850
- Cited by
- 180
- References
- 69
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 17 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 15 · 2019: 4 · 2018: 11 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 8 · 2013: 15 · 2012: 9
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- X-linked adrenoleukodystrophy, very long chain fatty acids, oligodendrocytes, astrocytes, hippocampus, mitochondrial depolarization, mitochondrial permeability transition, peroxisomal dysfunction, neurodegeneration, docosanoic acid, tetracosanoic acid, hexacosanoic acid, cell death
- MeSH terms
- Adrenoleukodystrophy, Animals, Astrocytes, Cells, Cultured, Fatty Acids, Hippocampus, Mitochondria, Neuroglia, Neurons, Oligodendroglia, Cell Death, Rats, Wistar, Reactive Oxygen Species, Calcium Signaling, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review